This site is intended for healthcare professionals
Drug news

EU CHMP recommends approval of GP 2013 (biosimilar rituximab) for follicular lymphoma and diffuse large B-cell lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis- Sandoz

Read time: 1 mins
Last updated:22nd Apr 2017
Published:22nd Apr 2017
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest